BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 15080506)

  • 21. Study of DHPS and DHFR genes of Pneumocystis jirovecii in Thai HIV-infected patients.
    Siripattanapipong S; Leelayoova S; Mungthin M; Worapong J; Tan-Ariya P
    Med Mycol; 2008 Jun; 46(4):389-92. PubMed ID: 18415849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [New aspects of epidemiology and treatment of Pneumocystis carinii infection].
    Powierska-Czarny J; Gospodarek E; Czerwionka-Szaflarska M
    Pol Merkur Lekarski; 2004 Nov; 17(101):534-7. PubMed ID: 15754652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Mutations of drug target molecules in Pneumocystis jirovecii isolates and future investigations].
    Takahashi T
    Nihon Ishinkin Gakkai Zasshi; 2009; 50(2):67-73. PubMed ID: 19430180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dihydropteroate synthase gene mutations in Pneumocystis and sulfa resistance.
    Huang L; Crothers K; Atzori C; Benfield T; Miller R; Rabodonirina M; Helweg-Larsen J
    Emerg Infect Dis; 2004 Oct; 10(10):1721-8. PubMed ID: 15504256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sulfa use, dihydropteroate synthase mutations, and Pneumocystis jirovecii pneumonia.
    Stein CR; Poole C; Kazanjian P; Meshnick SR
    Emerg Infect Dis; 2004 Oct; 10(10):1760-5. PubMed ID: 15504261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antifolates can have a role in the treatment of Plasmodium vivax.
    Hawkins VN; Joshi H; Rungsihirunrat K; Na-Bangchang K; Sibley CH
    Trends Parasitol; 2007 May; 23(5):213-22. PubMed ID: 17368986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pneumocystis carinii: where are we now?
    Watson J
    J HIV Ther; 2002 Feb; 7(1):8-12. PubMed ID: 11956498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV-associated Pneumocystis pneumonia.
    Huang L; Cattamanchi A; Davis JL; den Boon S; Kovacs J; Meshnick S; Miller RF; Walzer PD; Worodria W; Masur H; ;
    Proc Am Thorac Soc; 2011 Jun; 8(3):294-300. PubMed ID: 21653531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pneumocystis pneumonia: an update.
    Sritangratanakul S; Nuchprayoon S; Nuchprayoon I
    J Med Assoc Thai; 2004 Sep; 87 Suppl 2():S309-17. PubMed ID: 16083208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibitors of de novo folate enzymes in Plasmodium falciparum.
    Nzila A
    Drug Discov Today; 2006 Oct; 11(19-20):939-44. PubMed ID: 16997145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pneumocystis carinii mutations associated with sulfa and sulfone prophylaxis failures in immunocompromised patients.
    Armstrong W; Meshnick S; Kazanjian P
    Microbes Infect; 2000 Jan; 2(1):61-7. PubMed ID: 10717542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Are cytochrome b gene mutations the only cause of atovaquone resistance in Pneumocystis?
    Kaneshiro ES
    Drug Resist Updat; 2001 Oct; 4(5):322-9. PubMed ID: 11991686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atovaquone exposure and Pneumocystis jirovecii cytochrome b mutations: French data and review of the literature.
    Bonnet PL; Hoffmann CV; Le Nan N; Bellamy L; Hoarau G; Flori P; Demar M; Argy N; Morio F; Le Gal S; Nevez G
    Med Mycol; 2023 Sep; 61(9):. PubMed ID: 37656874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Update on Dihydropteroate Synthase (DHPS) Mutations in
    de la Horra C; Friaza V; Morilla R; Delgado J; Medrano FJ; Miller RF; de Armas Y; Calderón EJ
    J Fungi (Basel); 2021 Oct; 7(10):. PubMed ID: 34682277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modeling the molecular basis of atovaquone resistance in parasites and pathogenic fungi.
    Kessl JJ; Meshnick SR; Trumpower BL
    Trends Parasitol; 2007 Oct; 23(10):494-501. PubMed ID: 17826334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utility of the Biosynthetic Folate Pathway for Targets in Antimicrobial Discovery.
    Bourne CR
    Antibiotics (Basel); 2014 Jan; 3(1):1-28. PubMed ID: 27025730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic diversity of drug targets including dihydropteroate synthase, dihydrofolate reductase and cytochrome b, in Pneumocystis carinii f. sp. hominis isolates in Japan.
    Takahashi T; Kanda T; Iwamoto A
    Res Commun Mol Pathol Pharmacol; 2002; 112(1-4):159-76. PubMed ID: 15080506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Research progress on genes mutations related to sulfa drug resistance in
    Wang M; Zhu B
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2017 May; 46(5):563-569. PubMed ID: 29488726
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.